Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

被引：0
作者：
Hirsch Matani
Divya Sahu
Michael Paskewicz
Anastasia Gorbunova
Ashten N. Omstead
Rodney Wegner
Gene G. Finley
Blair A. Jobe
Ronan J. Kelly
Ali H. Zaidi
Ajay Goel
机构：
[1] Allegheny Health Network Cancer Institute,Division of Radiation Oncology
[2] Beckman Research Institute of City of Hope,Department of Molecular Diagnostics and Experimental Therapeutics
[3] Allegheny Health Network,Esophageal and Lung Research
[4] Charles A. Sammons Cancer Center,Department of Hematology and Oncology
[5] Baylor University Medical Center,undefined
来源：
Biomarker Research | / 10卷
关键词：
Esophageal adenocarcinoma; Risk stratification; CROSS regimen; EPHA5; BCL6; ERBB2; Predict response; Prognostic classifier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma [J].
Raja, Siva ;
Rice, Thomas W. ;
Murthy, Sudish C. ;
Ahmad, Usman ;
Semple, Marie E. ;
Blackstone, Eugene H. ;
Ishwaran, Hemant .
ANNALS OF SURGERY, 2021, 274 (04) :E320-E327
[32]   Paneth cell differentiation associated with neoadjuvant therapy in esophageal adenocarcinoma [J].
Ramineni, Madhurya ;
Findeis, Sarah K. ;
Ye, Jiqing ;
Hao, Yansheng .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 163 (01) :87-96
[33]   Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma [J].
Ming Zeng ;
Fernando N Aguila ;
Taral Patel ;
Mark Knapp ;
XueQiang Zhu ;
XiLin Chen ;
Phillip D Price .
World Journal of Gastrointestinal Oncology, 2016, 8 (05) :474-480
[34]   Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma [J].
Zeng, Ming ;
Aguila, Fernando N. ;
Patel, Taral ;
Knapp, Mark ;
Zhu, Xue-Qiang ;
Chen, Xi-Lin ;
Price, Phillip D. .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (05) :474-480
[35]   Neoadjuvant Chemotherapy and Surgery for Esophageal Adenocarcinoma: Prognostic Value of Circumferential Resection Margin and Stratification of N1 Category [J].
Arin Kumar Saha ;
Christopher Sutton ;
Olorunda Rotimi ;
Simon Dexter ;
Henry Sue-Ling ;
Abeezar I. Sarela .
Annals of Surgical Oncology, 2009, 16
[36]   The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation [J].
Kelly, Ronan J. ;
Zaidi, Ali H. ;
Smith, Matthew A. ;
Omstead, Ashten N. ;
Kosovec, Juliann E. ;
Matsui, Daisuke ;
Martin, Samantha A. ;
DiCarlo, Christina ;
Werts, E. Day ;
Silverman, Jan E. ;
Wang, David H. ;
Jobe, Blair A. .
ANNALS OF SURGERY, 2018, 268 (06) :992-999
[37]   Lymphatic Vessel Density as Prognostic Marker in Esophageal Adenocarcinoma [J].
Saad, Reda S. ;
Lindner, Jennifer L. ;
Liu, Yulin ;
Silverman, Jan F. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (01) :92-98
[38]   Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma [J].
Jiang, William ;
de Jong, Jelske M. ;
van Hillegersberg, Richard ;
Read, Matthew .
CANCERS, 2022, 14 (04)
[39]   P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy [J].
van Olphen, Sophie H. ;
Biermann, Katharina ;
Shapiro, Joel ;
Wijnhoven, Bas P. L. ;
Toxopeus, Eelke L. A. ;
van der Gaast, Ate ;
Stoop, Hans A. ;
van Lanschot, Jan J. B. ;
Spaander, Manon C. W. ;
Bruno, Marco J. ;
Looijenga, Leendert H. J. .
ANNALS OF SURGERY, 2017, 265 (02) :347-355
[40]   Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation [J].
Piro, Geny ;
Carbone, Carmine ;
Santoro, Raffaela ;
Tortora, Giampaolo ;
Melisi, Davide .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (04) :357-370
12345